Share Price and Basic Stock Data
Last Updated: January 17, 2026, 6:21 am
| PEG Ratio | -10.80 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Alkyl Amines Chemicals Ltd operates within the organic chemicals sector, focusing on the production of amines and their derivatives. The company’s stock price stood at ₹1,642, with a market capitalization of ₹8,396 Cr, reflecting a P/E ratio of 46.1. Over the past fiscal years, Alkyl Amines has demonstrated a notable sales trajectory, with revenues rising from ₹1,542 Cr in March 2022 to ₹1,683 Cr in March 2023. However, the company reported a decline in sales for the subsequent fiscal year, estimated at ₹1,441 Cr for March 2024. Quarterly sales figures revealed fluctuations, with the latest quarter ending September 2023 recording sales of ₹352 Cr, down from ₹410 Cr in June 2023. This trend indicates a potential volatility in demand and market conditions affecting revenue stability. The company’s sales performance over the years reflects its ability to adapt to market dynamics, but the recent decline raises concerns about future growth prospects.
Profitability and Efficiency Metrics
Alkyl Amines reported a net profit of ₹182 Cr, translating to a net profit margin of approximately 10.83%. The operating profit margin (OPM) stood at 18%, showcasing the company’s ability to maintain profitability despite fluctuating sales. The operating profit for March 2023 was recorded at ₹348 Cr, with a decline to ₹252 Cr anticipated for March 2024. Efficiency metrics reveal a cash conversion cycle (CCC) of 48 days, indicating a relatively efficient management of working capital. However, the return on equity (ROE) is at 14%, and the return on capital employed (ROCE) is at 18.7%, both of which are moderate compared to industry standards. The interest coverage ratio (ICR) of 25.70x demonstrates robust capacity to cover interest expenses, suggesting sound financial health. Nevertheless, the decline in profit margins, particularly in recent quarters, could signal increased operational challenges or rising costs that need to be addressed to sustain profitability.
Balance Sheet Strength and Financial Ratios
Alkyl Amines maintains a strong balance sheet, with total assets reported at ₹1,789 Cr and total liabilities at ₹1,584 Cr, yielding a debt-to-equity ratio of approximately 0.01, indicating low leverage. The company’s reserves have increased to ₹1,433 Cr, reflecting a solid equity base that supports growth initiatives. The current ratio stands at 1.65, suggesting adequate liquidity to meet short-term obligations. The price-to-book value (P/BV) ratio is currently at 4.58x, which, while higher than typical sector averages, may reflect investor confidence in the company’s growth potential. Additionally, the company has reported minimal borrowings of ₹2 Cr, reinforcing its financial stability. However, declining profitability metrics and a moderate return on equity may pose risks to maintaining this balance sheet strength in the face of potential market challenges.
Shareholding Pattern and Investor Confidence
The shareholding structure of Alkyl Amines indicates strong promoter confidence, with promoters holding 72.03% of the equity. This high level of ownership typically signals stability and alignment of interests between management and shareholders. Foreign institutional investors (FIIs) hold 3.44%, while domestic institutional investors (DIIs) account for 2.88%, reflecting moderate institutional interest. The public shareholding stands at 21.66%, with a total of 1,53,451 shareholders as of September 2025. This distribution suggests a healthy level of retail participation, although the declining number of shareholders from 2,08,334 in December 2022 to the current figure may indicate some investor apprehension amid recent profit declines. The gradual increase in FII holdings from 2.69% in December 2022 to the current level signifies growing confidence among foreign investors, which could enhance market perception and stability.
Outlook, Risks, and Final Insight
Looking ahead, Alkyl Amines faces both opportunities and challenges. The company’s strong balance sheet and low debt levels provide a robust platform for growth. However, the recent decline in sales and profitability raises concerns about market demand and operational efficiency. The volatility in quarterly sales performance may indicate underlying risks, including potential supply chain disruptions or increased competition. Additionally, global economic factors and regulatory changes in the chemicals sector could impact future earnings. To navigate these challenges, the company must focus on enhancing operational efficiencies and exploring new market opportunities. Should Alkyl Amines successfully address these risks while capitalizing on its strengths, it could maintain its position as a significant player in the organic chemicals market, fostering long-term shareholder value.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gujchem Distillers India Ltd | 74.6 Cr. | 209 | 456/192 | 173 | 392 | 0.05 % | 0.21 % | 0.09 % | 1.00 |
| Elantas Beck India Ltd | 6,966 Cr. | 8,787 | 14,250/8,150 | 50.4 | 1,177 | 0.09 % | 23.0 % | 17.4 % | 10.0 |
| Crestchem Ltd | 29.1 Cr. | 96.8 | 329/93.4 | 14.4 | 26.9 | 1.03 % | 59.9 % | 44.1 % | 10.0 |
| Chemiesynth (Vapi) Ltd | 11.6 Cr. | 37.6 | 37.6/35.8 | 32.8 | 0.00 % | 3.10 % | 0.99 % | 10.0 | |
| ARCL Organics Ltd | 235 Cr. | 293 | 435/163 | 13.0 | 108 | 0.00 % | 20.4 % | 16.8 % | 10.0 |
| Industry Average | 4,507.42 Cr | 1,453.52 | 60.07 | 334.84 | 0.41% | 14.71% | 10.69% | 7.56 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 409 | 388 | 412 | 410 | 352 | 322 | 357 | 400 | 415 | 371 | 386 | 406 | 389 |
| Expenses | 328 | 319 | 335 | 336 | 304 | 262 | 288 | 321 | 341 | 301 | 318 | 329 | 319 |
| Operating Profit | 81 | 70 | 78 | 74 | 48 | 60 | 69 | 79 | 74 | 71 | 68 | 77 | 70 |
| OPM % | 20% | 18% | 19% | 18% | 14% | 19% | 19% | 20% | 18% | 19% | 18% | 19% | 18% |
| Other Income | 2 | 5 | 2 | 5 | 2 | 5 | 3 | 5 | 9 | 7 | 9 | 8 | 7 |
| Interest | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 11 | 11 | 12 | 12 | 13 | 17 | 17 | 18 | 18 | 18 | 18 | 18 | 18 |
| Profit before tax | 71 | 63 | 67 | 66 | 36 | 46 | 53 | 66 | 64 | 59 | 59 | 66 | 59 |
| Tax % | 27% | 27% | 28% | 25% | 25% | 28% | 28% | 26% | 26% | 26% | 22% | 25% | 27% |
| Net Profit | 52 | 46 | 49 | 50 | 27 | 33 | 38 | 49 | 47 | 44 | 46 | 49 | 43 |
| EPS in Rs | 10.26 | 8.94 | 9.52 | 9.74 | 5.33 | 6.54 | 7.52 | 9.56 | 9.28 | 8.56 | 9.00 | 9.67 | 8.40 |
Last Updated: January 2, 2026, 1:34 pm
Below is a detailed analysis of the quarterly data for Alkyl Amines Chemicals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 389.00 Cr.. The value appears to be declining and may need further review. It has decreased from 406.00 Cr. (Jun 2025) to 389.00 Cr., marking a decrease of 17.00 Cr..
- For Expenses, as of Sep 2025, the value is 319.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 329.00 Cr. (Jun 2025) to 319.00 Cr., marking a decrease of 10.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 70.00 Cr.. The value appears to be declining and may need further review. It has decreased from 77.00 Cr. (Jun 2025) to 70.00 Cr., marking a decrease of 7.00 Cr..
- For OPM %, as of Sep 2025, the value is 18.00%. The value appears to be declining and may need further review. It has decreased from 19.00% (Jun 2025) to 18.00%, marking a decrease of 1.00%.
- For Other Income, as of Sep 2025, the value is 7.00 Cr.. The value appears to be declining and may need further review. It has decreased from 8.00 Cr. (Jun 2025) to 7.00 Cr., marking a decrease of 1.00 Cr..
- For Interest, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00 Cr..
- For Depreciation, as of Sep 2025, the value is 18.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 18.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 59.00 Cr.. The value appears to be declining and may need further review. It has decreased from 66.00 Cr. (Jun 2025) to 59.00 Cr., marking a decrease of 7.00 Cr..
- For Tax %, as of Sep 2025, the value is 27.00%. The value appears to be increasing, which may not be favorable. It has increased from 25.00% (Jun 2025) to 27.00%, marking an increase of 2.00%.
- For Net Profit, as of Sep 2025, the value is 43.00 Cr.. The value appears to be declining and may need further review. It has decreased from 49.00 Cr. (Jun 2025) to 43.00 Cr., marking a decrease of 6.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 8.40. The value appears to be declining and may need further review. It has decreased from 9.67 (Jun 2025) to 8.40, marking a decrease of 1.27.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:40 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 446 | 476 | 484 | 501 | 616 | 846 | 993 | 1,242 | 1,542 | 1,683 | 1,441 | 1,572 | 1,552 |
| Expenses | 362 | 390 | 393 | 405 | 499 | 682 | 736 | 812 | 1,216 | 1,335 | 1,189 | 1,280 | 1,267 |
| Operating Profit | 85 | 87 | 91 | 95 | 118 | 164 | 257 | 430 | 326 | 348 | 252 | 291 | 285 |
| OPM % | 19% | 18% | 19% | 19% | 19% | 19% | 26% | 35% | 21% | 21% | 17% | 19% | 18% |
| Other Income | 2 | 2 | 2 | 1 | 2 | 4 | 40 | 6 | 14 | 9 | 14 | 30 | 31 |
| Interest | 12 | 10 | 8 | 8 | 8 | 15 | 10 | 6 | 3 | 3 | 4 | 1 | 1 |
| Depreciation | 10 | 11 | 13 | 14 | 16 | 23 | 27 | 29 | 35 | 45 | 59 | 71 | 72 |
| Profit before tax | 65 | 67 | 72 | 74 | 96 | 130 | 260 | 401 | 302 | 309 | 202 | 249 | 244 |
| Tax % | 34% | 32% | 31% | 32% | 33% | 36% | 17% | 26% | 26% | 26% | 26% | 25% | |
| Net Profit | 43 | 45 | 50 | 50 | 64 | 84 | 215 | 295 | 225 | 229 | 149 | 186 | 182 |
| EPS in Rs | 8.41 | 8.91 | 9.77 | 9.87 | 12.61 | 16.42 | 42.21 | 57.91 | 44.04 | 44.75 | 29.12 | 36.39 | 35.63 |
| Dividend Payout % | 19% | 18% | 41% | 20% | 22% | 20% | 19% | 17% | 23% | 22% | 34% | 28% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 4.65% | 11.11% | 0.00% | 28.00% | 31.25% | 155.95% | 37.21% | -23.73% | 1.78% | -34.93% | 24.83% |
| Change in YoY Net Profit Growth (%) | 0.00% | 6.46% | -11.11% | 28.00% | 3.25% | 124.70% | -118.74% | -60.94% | 25.51% | -36.71% | 59.77% |
Alkyl Amines Chemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 10% |
| 3 Years: | 1% |
| TTM: | 10% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 0% |
| 3 Years: | -6% |
| TTM: | 26% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 33% |
| 5 Years: | 9% |
| 3 Years: | -11% |
| 1 Year: | -3% |
| Return on Equity | |
|---|---|
| 10 Years: | 23% |
| 5 Years: | 21% |
| 3 Years: | 16% |
| Last Year: | 14% |
Last Updated: September 4, 2025, 10:50 pm
Balance Sheet
Last Updated: December 4, 2025, 12:56 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Reserves | 130 | 165 | 189 | 235 | 287 | 355 | 526 | 782 | 980 | 1,159 | 1,257 | 1,392 | 1,433 |
| Borrowings | 151 | 135 | 111 | 120 | 181 | 165 | 87 | 47 | 23 | 88 | 3 | 6 | 2 |
| Other Liabilities | 98 | 93 | 95 | 147 | 159 | 218 | 160 | 306 | 359 | 335 | 314 | 381 | 322 |
| Total Liabilities | 388 | 402 | 406 | 512 | 637 | 749 | 783 | 1,145 | 1,371 | 1,592 | 1,584 | 1,789 | 1,767 |
| Fixed Assets | 155 | 151 | 187 | 220 | 355 | 376 | 423 | 458 | 629 | 719 | 1,089 | 1,044 | 1,039 |
| CWIP | 3 | 31 | 16 | 35 | 18 | 43 | 45 | 138 | 143 | 352 | 36 | 52 | 76 |
| Investments | 2 | 2 | 2 | 1 | 1 | 1 | 0 | 30 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 229 | 218 | 201 | 256 | 262 | 328 | 315 | 520 | 600 | 521 | 459 | 693 | 651 |
| Total Assets | 388 | 402 | 406 | 512 | 637 | 749 | 783 | 1,145 | 1,371 | 1,592 | 1,584 | 1,789 | 1,767 |
Below is a detailed analysis of the balance sheet data for Alkyl Amines Chemicals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 10.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 10.00 Cr..
- For Reserves, as of Sep 2025, the value is 1,433.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,392.00 Cr. (Mar 2025) to 1,433.00 Cr., marking an increase of 41.00 Cr..
- For Borrowings, as of Sep 2025, the value is 2.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 6.00 Cr. (Mar 2025) to 2.00 Cr., marking a decrease of 4.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 322.00 Cr.. The value appears to be improving (decreasing). It has decreased from 381.00 Cr. (Mar 2025) to 322.00 Cr., marking a decrease of 59.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 1,767.00 Cr.. The value appears to be improving (decreasing). It has decreased from 1,789.00 Cr. (Mar 2025) to 1,767.00 Cr., marking a decrease of 22.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 1,039.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,044.00 Cr. (Mar 2025) to 1,039.00 Cr., marking a decrease of 5.00 Cr..
- For CWIP, as of Sep 2025, the value is 76.00 Cr.. The value appears strong and on an upward trend. It has increased from 52.00 Cr. (Mar 2025) to 76.00 Cr., marking an increase of 24.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 651.00 Cr.. The value appears to be declining and may need further review. It has decreased from 693.00 Cr. (Mar 2025) to 651.00 Cr., marking a decrease of 42.00 Cr..
- For Total Assets, as of Sep 2025, the value is 1,767.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,789.00 Cr. (Mar 2025) to 1,767.00 Cr., marking a decrease of 22.00 Cr..
Notably, the Reserves (1,433.00 Cr.) exceed the Borrowings (2.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -66.00 | -48.00 | -20.00 | -25.00 | -63.00 | -1.00 | 170.00 | 383.00 | 303.00 | 260.00 | 249.00 | 285.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 73 | 76 | 68 | 71 | 73 | 66 | 60 | 67 | 66 | 56 | 56 | 54 |
| Inventory Days | 133 | 105 | 92 | 165 | 99 | 88 | 67 | 91 | 76 | 82 | 85 | 75 |
| Days Payable | 79 | 58 | 63 | 120 | 78 | 104 | 57 | 133 | 105 | 84 | 85 | 80 |
| Cash Conversion Cycle | 128 | 123 | 96 | 116 | 94 | 51 | 71 | 25 | 36 | 53 | 56 | 48 |
| Working Capital Days | 96 | 93 | 87 | 84 | 76 | 56 | 54 | 26 | 35 | 28 | 47 | 42 |
| ROCE % | 28% | 26% | 26% | 24% | 25% | 29% | 41% | 56% | 33% | 28% | 16% | 19% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| HSBC Small Cap Fund | 460,300 | 0.48 | 77.35 | N/A | N/A | N/A |
| Aditya Birla Sun Life Business Cycle Fund | 71,982 | 0.67 | 12.1 | N/A | N/A | N/A |
| Aditya Birla Sun Life Manufacturing Equity Fund | 57,147 | 0.87 | 9.6 | N/A | N/A | N/A |
| ICICI Prudential Commodities Fund | 14,952 | 0.08 | 2.51 | N/A | N/A | N/A |
| ICICI Prudential Multicap Fund | 5,812 | 0.01 | 0.98 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 |
|---|---|---|---|---|---|
| FaceValue | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| Basic EPS (Rs.) | 98.71 | 42.22 | 32.36 | 25.41 | 24.53 |
| Diluted EPS (Rs.) | 98.44 | 42.10 | 32.36 | 25.41 | 24.53 |
| Cash EPS (Rs.) | 109.66 | 51.66 | 39.53 | 31.67 | 30.79 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 262.88 | 185.71 | 151.39 | 125.32 | 102.02 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 262.88 | 185.71 | 151.39 | 125.32 | 102.44 |
| Revenue From Operations / Share (Rs.) | 486.42 | 414.66 | 301.87 | 245.27 | 236.92 |
| PBDIT / Share (Rs.) | 129.11 | 81.65 | 58.94 | 47.16 | 45.83 |
| PBIT / Share (Rs.) | 115.93 | 70.22 | 50.69 | 40.17 | 39.51 |
| PBT / Share (Rs.) | 118.25 | 62.98 | 46.70 | 36.22 | 35.58 |
| Net Profit / Share (Rs.) | 96.48 | 40.22 | 31.28 | 24.67 | 24.48 |
| NP After MI And SOA / Share (Rs.) | 98.63 | 42.18 | 32.33 | 25.39 | 24.51 |
| PBDIT Margin (%) | 26.54 | 19.69 | 19.52 | 19.23 | 19.34 |
| PBIT Margin (%) | 23.83 | 16.93 | 16.79 | 16.37 | 16.67 |
| PBT Margin (%) | 24.30 | 15.18 | 15.47 | 14.76 | 15.01 |
| Net Profit Margin (%) | 19.83 | 9.70 | 10.36 | 10.05 | 10.33 |
| NP After MI And SOA Margin (%) | 20.27 | 10.17 | 10.71 | 10.35 | 10.34 |
| Return on Networth / Equity (%) | 37.51 | 22.71 | 21.35 | 20.25 | 24.02 |
| Return on Capital Employeed (%) | 37.58 | 27.83 | 22.04 | 22.65 | 28.29 |
| Return On Assets (%) | 25.69 | 11.29 | 10.17 | 9.91 | 12.03 |
| Long Term Debt / Equity (X) | 0.08 | 0.20 | 0.35 | 0.25 | 0.21 |
| Total Debt / Equity (X) | 0.08 | 0.34 | 0.48 | 0.39 | 0.47 |
| Asset Turnover Ratio (%) | 1.28 | 1.21 | 1.06 | 1.08 | 1.18 |
| Current Ratio (X) | 1.91 | 1.26 | 1.33 | 1.40 | 1.42 |
| Quick Ratio (X) | 1.37 | 0.83 | 0.85 | 0.70 | 0.93 |
| Inventory Turnover Ratio (X) | 5.03 | 5.05 | 3.29 | 3.00 | 3.90 |
| Dividend Payout Ratio (NP) (%) | 18.23 | 16.58 | 15.45 | 0.00 | 40.76 |
| Dividend Payout Ratio (CP) (%) | 16.08 | 13.04 | 12.31 | 0.00 | 32.41 |
| Earning Retention Ratio (%) | 81.77 | 83.42 | 84.55 | 0.00 | 59.24 |
| Cash Earning Retention Ratio (%) | 83.92 | 86.96 | 87.69 | 0.00 | 67.59 |
| Interest Coverage Ratio (X) | 25.70 | 11.29 | 14.76 | 11.95 | 11.64 |
| Interest Coverage Ratio (Post Tax) (X) | 18.74 | 6.56 | 8.83 | 7.25 | 7.22 |
| Enterprise Value (Cr.) | 2474.74 | 1821.38 | 1383.38 | 1017.13 | 733.06 |
| EV / Net Operating Revenue (X) | 2.49 | 2.15 | 2.25 | 2.03 | 1.52 |
| EV / EBITDA (X) | 9.39 | 10.93 | 11.50 | 10.56 | 7.84 |
| MarketCap / Net Operating Revenue (X) | 2.48 | 2.02 | 2.01 | 1.84 | 1.33 |
| Retention Ratios (%) | 81.76 | 83.41 | 84.54 | 0.00 | 59.23 |
| Price / BV (X) | 4.58 | 4.52 | 4.00 | 3.60 | 3.08 |
| Price / Net Operating Revenue (X) | 2.48 | 2.02 | 2.01 | 1.84 | 1.33 |
| EarningsYield | 0.08 | 0.05 | 0.05 | 0.05 | 0.07 |
After reviewing the key financial ratios for Alkyl Amines Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 20, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 19) which recorded 5.00.
- For Basic EPS (Rs.), as of Mar 20, the value is 98.71. This value is within the healthy range. It has increased from 42.22 (Mar 19) to 98.71, marking an increase of 56.49.
- For Diluted EPS (Rs.), as of Mar 20, the value is 98.44. This value is within the healthy range. It has increased from 42.10 (Mar 19) to 98.44, marking an increase of 56.34.
- For Cash EPS (Rs.), as of Mar 20, the value is 109.66. This value is within the healthy range. It has increased from 51.66 (Mar 19) to 109.66, marking an increase of 58.00.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 20, the value is 262.88. It has increased from 185.71 (Mar 19) to 262.88, marking an increase of 77.17.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 20, the value is 262.88. It has increased from 185.71 (Mar 19) to 262.88, marking an increase of 77.17.
- For Revenue From Operations / Share (Rs.), as of Mar 20, the value is 486.42. It has increased from 414.66 (Mar 19) to 486.42, marking an increase of 71.76.
- For PBDIT / Share (Rs.), as of Mar 20, the value is 129.11. This value is within the healthy range. It has increased from 81.65 (Mar 19) to 129.11, marking an increase of 47.46.
- For PBIT / Share (Rs.), as of Mar 20, the value is 115.93. This value is within the healthy range. It has increased from 70.22 (Mar 19) to 115.93, marking an increase of 45.71.
- For PBT / Share (Rs.), as of Mar 20, the value is 118.25. This value is within the healthy range. It has increased from 62.98 (Mar 19) to 118.25, marking an increase of 55.27.
- For Net Profit / Share (Rs.), as of Mar 20, the value is 96.48. This value is within the healthy range. It has increased from 40.22 (Mar 19) to 96.48, marking an increase of 56.26.
- For NP After MI And SOA / Share (Rs.), as of Mar 20, the value is 98.63. This value is within the healthy range. It has increased from 42.18 (Mar 19) to 98.63, marking an increase of 56.45.
- For PBDIT Margin (%), as of Mar 20, the value is 26.54. This value is within the healthy range. It has increased from 19.69 (Mar 19) to 26.54, marking an increase of 6.85.
- For PBIT Margin (%), as of Mar 20, the value is 23.83. This value exceeds the healthy maximum of 20. It has increased from 16.93 (Mar 19) to 23.83, marking an increase of 6.90.
- For PBT Margin (%), as of Mar 20, the value is 24.30. This value is within the healthy range. It has increased from 15.18 (Mar 19) to 24.30, marking an increase of 9.12.
- For Net Profit Margin (%), as of Mar 20, the value is 19.83. This value exceeds the healthy maximum of 10. It has increased from 9.70 (Mar 19) to 19.83, marking an increase of 10.13.
- For NP After MI And SOA Margin (%), as of Mar 20, the value is 20.27. This value exceeds the healthy maximum of 20. It has increased from 10.17 (Mar 19) to 20.27, marking an increase of 10.10.
- For Return on Networth / Equity (%), as of Mar 20, the value is 37.51. This value is within the healthy range. It has increased from 22.71 (Mar 19) to 37.51, marking an increase of 14.80.
- For Return on Capital Employeed (%), as of Mar 20, the value is 37.58. This value is within the healthy range. It has increased from 27.83 (Mar 19) to 37.58, marking an increase of 9.75.
- For Return On Assets (%), as of Mar 20, the value is 25.69. This value is within the healthy range. It has increased from 11.29 (Mar 19) to 25.69, marking an increase of 14.40.
- For Long Term Debt / Equity (X), as of Mar 20, the value is 0.08. This value is below the healthy minimum of 0.2. It has decreased from 0.20 (Mar 19) to 0.08, marking a decrease of 0.12.
- For Total Debt / Equity (X), as of Mar 20, the value is 0.08. This value is within the healthy range. It has decreased from 0.34 (Mar 19) to 0.08, marking a decrease of 0.26.
- For Asset Turnover Ratio (%), as of Mar 20, the value is 1.28. It has increased from 1.21 (Mar 19) to 1.28, marking an increase of 0.07.
- For Current Ratio (X), as of Mar 20, the value is 1.91. This value is within the healthy range. It has increased from 1.26 (Mar 19) to 1.91, marking an increase of 0.65.
- For Quick Ratio (X), as of Mar 20, the value is 1.37. This value is within the healthy range. It has increased from 0.83 (Mar 19) to 1.37, marking an increase of 0.54.
- For Inventory Turnover Ratio (X), as of Mar 20, the value is 5.03. This value is within the healthy range. It has decreased from 5.05 (Mar 19) to 5.03, marking a decrease of 0.02.
- For Dividend Payout Ratio (NP) (%), as of Mar 20, the value is 18.23. This value is below the healthy minimum of 20. It has increased from 16.58 (Mar 19) to 18.23, marking an increase of 1.65.
- For Dividend Payout Ratio (CP) (%), as of Mar 20, the value is 16.08. This value is below the healthy minimum of 20. It has increased from 13.04 (Mar 19) to 16.08, marking an increase of 3.04.
- For Earning Retention Ratio (%), as of Mar 20, the value is 81.77. This value exceeds the healthy maximum of 70. It has decreased from 83.42 (Mar 19) to 81.77, marking a decrease of 1.65.
- For Cash Earning Retention Ratio (%), as of Mar 20, the value is 83.92. This value exceeds the healthy maximum of 70. It has decreased from 86.96 (Mar 19) to 83.92, marking a decrease of 3.04.
- For Interest Coverage Ratio (X), as of Mar 20, the value is 25.70. This value is within the healthy range. It has increased from 11.29 (Mar 19) to 25.70, marking an increase of 14.41.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 20, the value is 18.74. This value is within the healthy range. It has increased from 6.56 (Mar 19) to 18.74, marking an increase of 12.18.
- For Enterprise Value (Cr.), as of Mar 20, the value is 2,474.74. It has increased from 1,821.38 (Mar 19) to 2,474.74, marking an increase of 653.36.
- For EV / Net Operating Revenue (X), as of Mar 20, the value is 2.49. This value is within the healthy range. It has increased from 2.15 (Mar 19) to 2.49, marking an increase of 0.34.
- For EV / EBITDA (X), as of Mar 20, the value is 9.39. This value is within the healthy range. It has decreased from 10.93 (Mar 19) to 9.39, marking a decrease of 1.54.
- For MarketCap / Net Operating Revenue (X), as of Mar 20, the value is 2.48. This value is within the healthy range. It has increased from 2.02 (Mar 19) to 2.48, marking an increase of 0.46.
- For Retention Ratios (%), as of Mar 20, the value is 81.76. This value exceeds the healthy maximum of 70. It has decreased from 83.41 (Mar 19) to 81.76, marking a decrease of 1.65.
- For Price / BV (X), as of Mar 20, the value is 4.58. This value exceeds the healthy maximum of 3. It has increased from 4.52 (Mar 19) to 4.58, marking an increase of 0.06.
- For Price / Net Operating Revenue (X), as of Mar 20, the value is 2.48. This value is within the healthy range. It has increased from 2.02 (Mar 19) to 2.48, marking an increase of 0.46.
- For EarningsYield, as of Mar 20, the value is 0.08. This value is below the healthy minimum of 5. It has increased from 0.05 (Mar 19) to 0.08, marking an increase of 0.03.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Alkyl Amines Chemicals Ltd:
- Net Profit Margin: 19.83%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 37.58% (Industry Average ROCE: 14.71%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 37.51% (Industry Average ROE: 10.69%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 18.74
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.37
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 44.8 (Industry average Stock P/E: 60.07)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.08
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 19.83%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Organic - Others | 401-407, Nirman Vyapar Kendra, Plot No. 10, Sector 17, New Mumbai Maharashtra 400703 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Yogesh M Kothari | Chairman & Managing Director |
| Mr. Kirat M Patel | Executive Director |
| Mr. Suneet Y Kothari | Executive Director |
| Mr. Premal N Kapadia | Non Executive Director |
| Mr. Rakesh S Goyal | Whole-Time Director (Operations) |
| Mrs. Leja S Hattiangadi | Independent Director |
| Mr. Chandrashekhar R Gupte | Independent Director |
| Mr. Ravi B Kapoor | Independent Director |
| Mr. Ashwin Ramanathan | Independent Director |
| Mrs. Bhavna G Doshi | Independent Director |
FAQ
What is the intrinsic value of Alkyl Amines Chemicals Ltd?
Alkyl Amines Chemicals Ltd's intrinsic value (as of 17 January 2026) is ₹1364.79 which is 14.43% lower the current market price of ₹1,595.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹8,158 Cr. market cap, FY2025-2026 high/low of ₹2,449/1,507, reserves of ₹1,433 Cr, and liabilities of ₹1,767 Cr.
What is the Market Cap of Alkyl Amines Chemicals Ltd?
The Market Cap of Alkyl Amines Chemicals Ltd is 8,158 Cr..
What is the current Stock Price of Alkyl Amines Chemicals Ltd as on 17 January 2026?
The current stock price of Alkyl Amines Chemicals Ltd as on 17 January 2026 is ₹1,595.
What is the High / Low of Alkyl Amines Chemicals Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Alkyl Amines Chemicals Ltd stocks is ₹2,449/1,507.
What is the Stock P/E of Alkyl Amines Chemicals Ltd?
The Stock P/E of Alkyl Amines Chemicals Ltd is 44.8.
What is the Book Value of Alkyl Amines Chemicals Ltd?
The Book Value of Alkyl Amines Chemicals Ltd is 282.
What is the Dividend Yield of Alkyl Amines Chemicals Ltd?
The Dividend Yield of Alkyl Amines Chemicals Ltd is 0.63 %.
What is the ROCE of Alkyl Amines Chemicals Ltd?
The ROCE of Alkyl Amines Chemicals Ltd is 18.7 %.
What is the ROE of Alkyl Amines Chemicals Ltd?
The ROE of Alkyl Amines Chemicals Ltd is 14.0 %.
What is the Face Value of Alkyl Amines Chemicals Ltd?
The Face Value of Alkyl Amines Chemicals Ltd is 2.00.